The Vienna Prediction Model for identifying patients at low risk of recurrent venous thromboembolism: a prospective cohort study

医学 危险系数 前瞻性队列研究 肺栓塞 置信区间 深静脉 静脉血栓栓塞 静脉血栓形成 临床终点 血栓形成 比例危险模型 队列 队列研究 析因分析 外科 内科学 临床试验
作者
Paul A. Kyrle,Lisbeth Eischer,Hana Šinkovec,Paul Gressenberger,Gary Tse,Marianne Brodmann,Georg Heinze,Sabine Eichinger
出处
期刊:European Heart Journal [Oxford University Press]
标识
DOI:10.1093/eurheartj/ehad618
摘要

Abstract Background and Aims Patients with unprovoked venous thromboembolism (VTE) have a high recurrence risk, and guidelines suggest extended-phase anticoagulation. Many patients never experience recurrence but are exposed to bleeding. The aim of this study was to assess the performance of the Vienna Prediction Model (VPM) and to evaluate if the VPM accurately identifies these patients. Methods In patients with unprovoked VTE, the VPM was performed 3 weeks after anticoagulation withdrawal. Those with a predicted 1-year recurrence risk of ≤5.5% were prospectively followed. Study endpoint was recurrent VTE over 2 years. Results A total of 818 patients received anticoagulation for a median of 3.9 months. 520 patients (65%) had a predicted annual recurrence risk of ≤5.5%. During a median time of 23.9 months, 52 patients had non-fatal recurrence. The recurrence risk was 5.2% [95% confidence interval (CI) 3.2–7.2] at 1 year and 11.2% (95% CI 8.3–14) at 2 years. Model calibration was adequate after 1 year. The VPM underestimated the recurrence risk of patients with a 2-year recurrence rate of >5%. In a post-hoc analysis, the VPM’s baseline hazard was recalibrated. Bootstrap validation confirmed an ideal ratio of observed and expected recurrence events. The recurrence risk was highest in men with proximal deep-vein thrombosis or pulmonary embolism and lower in women regardless of the site of incident VTE. Conclusions In this prospective evaluation of the performance of the VPM, the 1-year rate of recurrence in patients with unprovoked VTE was 5.2%. Recalibration improved identification of patients at low recurrence risk and stratification into distinct low-risk categories.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
PhD完成签到,获得积分10
1秒前
1秒前
2秒前
传奇3应助MLJ采纳,获得10
2秒前
哎呀妈呀完成签到,获得积分10
2秒前
干净海秋发布了新的文献求助10
3秒前
3秒前
5秒前
5秒前
6秒前
Evooolet完成签到,获得积分10
6秒前
ding应助凡是过往皆为序章采纳,获得10
8秒前
干净海秋完成签到,获得积分10
8秒前
小蘑菇应助zd采纳,获得10
8秒前
Ava应助别偷我增肌粉采纳,获得30
8秒前
abc完成签到,获得积分10
9秒前
一点通发布了新的文献求助10
10秒前
13秒前
淡淡的豁应助棒棒采纳,获得150
15秒前
小秋完成签到,获得积分10
15秒前
华仔应助木木林采纳,获得10
15秒前
QIZH发布了新的文献求助10
15秒前
FashionBoy应助py999采纳,获得10
16秒前
小马甲应助圆蓬蓬采纳,获得10
17秒前
17秒前
Orange应助陈念采纳,获得10
18秒前
18秒前
热心又蓝完成签到,获得积分10
19秒前
111发布了新的文献求助10
19秒前
曾经晓亦发布了新的文献求助20
19秒前
量子星尘发布了新的文献求助10
19秒前
FashionBoy应助一点通采纳,获得10
19秒前
害怕的冬云完成签到,获得积分10
20秒前
丘比特应助nni采纳,获得20
22秒前
陈一完成签到 ,获得积分10
22秒前
现代完成签到,获得积分10
23秒前
尹天奇发布了新的文献求助10
23秒前
23秒前
SYLH应助QIZH采纳,获得10
24秒前
结实的泥猴桃完成签到 ,获得积分10
25秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975755
求助须知:如何正确求助?哪些是违规求助? 3520108
关于积分的说明 11200829
捐赠科研通 3256492
什么是DOI,文献DOI怎么找? 1798298
邀请新用户注册赠送积分活动 877509
科研通“疑难数据库(出版商)”最低求助积分说明 806403